Skip to content
Screener

Common Stock at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$2M0.0%
NeoGenomics logo
NeoGenomicsNEO
$130K+1.6%
Illumina logo
IlluminaILMN
$2M0.0%
Veracyte logo
VeracyteVCYT
125M0.0%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$11K-92.5%
Guardant Health logo
Guardant HealthGH
$1K0.0%

Other financials

Income statement

See full
Revenue$15.5M-24.9%
Gross profit$281.0K-96.1%
Operating income-$32.2M-81.7%
Net income-$30.0M-90.7%
EPS (diluted)-$0.29-61.1%

Balance sheet

See full
Cash & equivalents$73.6M+3.7%
Total debt$39.0M-6.2%
Total equity$254.8M+22.9%
Total assets$325.4M+19.1%

Cash flow

See full
Operating cash flow-$22.5M-25.1%
CapEx$3.2M+27.1%
Free cash flow-$25.7M-25.4%

Valuation

See full
Market cap$1.51B+279%
Enterprise value$1.48B+283%
P/S23.4×+18.5×

Profitability

See full
Gross margin13.7%-19.6pp
Operating margin-158.9%-5,457pp
Net margin-148.1%+154pp
FCF margin-131.2%-453pp

Returns & leverage

See full
Return on equity-41.4%-6.7pp
Debt / equity0.2×0.0×
Current ratio6.6×-0.3×

Where this comes from

Reported directly by Personalis, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValueOutstanding.

The source filing: Personalis, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:10 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211896
Line itemMarch 31, 2026December 31, 2025
Commitments and contingencies (Note 11)
Stockholders’ equity
Preferred stock, $0.0001 par value — 10,000,000 shares authorized; none issued
Common stock, $0.0001 par value — 200,000,000 shares authorized; 104,691,704 and 102,475,891 shares issued and outstanding, respectively1010
Additional paid-in capital916,117892,331
Accumulated other comprehensive income (loss)(70)104
Accumulated deficit(661,292)(631,260)
Total stockholders’ equity254,765261,185

Item 1. Financial Statements

FAQ

What is Personalis, Inc.'s common stock?
Personalis, Inc. (PSNL) reported common stock of $10K in Q1 2026.
How has Personalis, Inc.'s common stock changed year-over-year?
Personalis, Inc.'s common stock increased by 11.1% year-over-year, from $9K to $10K.
What is the long-term trend for Personalis, Inc.'s common stock?
Over 5 years (2020 to 2025), Personalis, Inc.'s common stock has grown at a 20.1% compound annual growth rate (CAGR), from $4K to $10K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about Personalis, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude